FDA NDC Directory · JSON-LD · Markdown

RANOLAZINE

NDC 72319-021 · HUMAN PRESCRIPTION DRUG · TABLET, FILM COATED, EXTENDED RELEASE

Labeler / Manufactureri3 Pharmaceuticals, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA213517
Dosage form / routeTABLET, FILM COATED, EXTENDED RELEASE · ORAL
Active ingredientsRANOLAZINE (500 mg/1)
Marketing started20220615
Package count1

External sources

Source: openFDA. Public-domain (CC0).